JME Society for Endocrinology Archive
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Journal of Molecular Endocrinology (2006) 37 533-540    DOI: 10.1677/jme.1.02119
© 2006 Society for Endocrinology

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (3)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yang, R.
Right arrow Articles by Ni, X.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yang, R.
Right arrow Articles by Ni, X.

Corticotropin-releasing hormone inhibits progesterone production in cultured human placental trophoblasts

Ruifang Yang*, Xingji You*, Xiaolu Tang, Lu Gao and Xin Ni

Department of Physiology, Second Military Medical University, 800 Xiangyin Road, Shanghai 200433, People’s Republic of China

(Requests for offprints should be addressed to X Ni; Email: nxljq2003{at}yahoo.com.cn)

* (R Yang and X You contributed equally to this work)

Placental-derived corticotropin-releasing hormone (CRH) seems to play a major role in the mechanisms controlling human pregnancy and parturition. It has been suggested that CRH directly modulates the endocrine function of placental trophoblasts, including the production of estrogen, ACTH, and prostaglandin. In this study, we sought to investigate the effect of CRH, locally produced by placenta, on progesterone production. Percoll-purified placental trophoblasts were obtained from uncomplicated term pregnancies and cultured for 72 h. Progesterone concentration in culture media was measured by RIA. The mRNA transcripts encoding CYP11A1 and HSD3B1, the enzymes for progesterone synthesis, were determined by quantitative real-time reverse transcription (RT)-PCR. Results showed that CRH (10–8–10–6 mol/l) caused a significant decrease in progesterone levels in a dose-dependent manner. The CRH antagonist, {alpha}-helical CRH 9-41, at 10–7–10–5 mol/l stimulated progesterone secretion. Consistent with this thesis, CRH decreased, whereas {alpha}-helical CRH increased, the mRNA levels of CYP11A1 and HSD3B1. Since CRH has been shown to activate the phospholipase C–protein kinase C (PKC) signal pathway in placenta, we examined whether the effect of CRH on progesterone synthesis was dependent on PKC signal pathway. Treatment of cells with PKC inhibitor, Gö6976, resulted in a significant increase in progesterone production, and exogenous CRH restored progesterone production. In conclusion, placental CRH exhibits a tonic inhibitory effect on progesterone production in a PKC-dependent fashion.




This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
R. Smith, J. I. Smith, X. Shen, P. J. Engel, M. E. Bowman, S. A. McGrath, A. M. Bisits, P. McElduff, W. B. Giles, and D. W. Smith
Patterns of Plasma Corticotropin-Releasing Hormone, Progesterone, Estradiol, and Estriol Change and the Onset of Human Labor
J. Clin. Endocrinol. Metab., June 1, 2009; 94(6): 2066 - 2074.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
L. Gao, C. Lu, C. Xu, Y. Tao, B. Cong, and X. Ni
Differential Regulation of Prostaglandin Production Mediated by Corticotropin-Releasing Hormone Receptor Type 1 and Type 2 in Cultured Human Placental Trophoblasts
Endocrinology, June 1, 2008; 149(6): 2866 - 2876.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by the Society for Endocrinology.